Logo image of BCSF

BAIN CAPITAL SPECIALTY FINAN (BCSF) Stock Fundamental Analysis

USA - NYSE:BCSF - US05684B1070 - Common Stock

14.23 USD
+0.22 (+1.57%)
Last: 10/21/2025, 8:04:00 PM
14.68 USD
+0.45 (+3.16%)
After Hours: 10/21/2025, 8:04:00 PM
Fundamental Rating

4

BCSF gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 236 industry peers in the Capital Markets industry. There are concerns on the financial health of BCSF while its profitability can be described as average. BCSF has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

BCSF had positive earnings in the past year.
BCSF had a negative operating cash flow in the past year.
Each year in the past 5 years BCSF has been profitable.
In multiple years BCSF reported negative operating cash flow during the last 5 years.
BCSF Yearly Net Income VS EBIT VS OCF VS FCFBCSF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

BCSF's Return On Assets of 3.87% is in line compared to the rest of the industry. BCSF outperforms 58.90% of its industry peers.
BCSF's Return On Equity of 9.44% is in line compared to the rest of the industry. BCSF outperforms 52.97% of its industry peers.
BCSF's Return On Invested Capital of 3.90% is in line compared to the rest of the industry. BCSF outperforms 53.39% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BCSF is below the industry average of 7.56%.
Industry RankSector Rank
ROA 3.87%
ROE 9.44%
ROIC 3.9%
ROA(3y)4.53%
ROA(5y)3.71%
ROE(3y)10.26%
ROE(5y)8.49%
ROIC(3y)4.13%
ROIC(5y)3.56%
BCSF Yearly ROA, ROE, ROICBCSF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

BCSF has a Profit Margin of 37.89%. This is amongst the best in the industry. BCSF outperforms 80.08% of its industry peers.
In the last couple of years the Profit Margin of BCSF has declined.
BCSF has a better Operating Margin (47.50%) than 82.20% of its industry peers.
BCSF's Operating Margin has improved in the last couple of years.
BCSF's Gross Margin of 51.17% is fine compared to the rest of the industry. BCSF outperforms 60.59% of its industry peers.
BCSF's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 47.5%
PM (TTM) 37.89%
GM 51.17%
OM growth 3Y2.21%
OM growth 5Y2.08%
PM growth 3Y-12.39%
PM growth 5Y-3.82%
GM growth 3Y2.62%
GM growth 5Y2.37%
BCSF Yearly Profit, Operating, Gross MarginsBCSF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

2

2. Health

2.1 Basic Checks

The number of shares outstanding for BCSF remains at a similar level compared to 1 year ago.
Compared to 5 years ago, BCSF has more shares outstanding
Compared to 1 year ago, BCSF has a worse debt to assets ratio.
BCSF Yearly Shares OutstandingBCSF Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
BCSF Yearly Total Debt VS Total AssetsBCSF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

BCSF has an Altman-Z score of 0.60. This is a bad value and indicates that BCSF is not financially healthy and even has some risk of bankruptcy.
BCSF has a Altman-Z score of 0.60. This is in the lower half of the industry: BCSF underperforms 60.17% of its industry peers.
A Debt/Equity ratio of 1.37 is on the high side and indicates that BCSF has dependencies on debt financing.
BCSF's Debt to Equity ratio of 1.37 is on the low side compared to the rest of the industry. BCSF is outperformed by 66.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF N/A
Altman-Z 0.6
ROIC/WACCN/A
WACCN/A
BCSF Yearly LT Debt VS Equity VS FCFBCSF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.63 indicates that BCSF should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.63, BCSF is doing good in the industry, outperforming 67.37% of the companies in the same industry.
BCSF has a Quick Ratio of 1.63. This is a normal value and indicates that BCSF is financially healthy and should not expect problems in meeting its short term obligations.
BCSF has a better Quick ratio (1.63) than 67.37% of its industry peers.
Industry RankSector Rank
Current Ratio 1.63
Quick Ratio 1.63
BCSF Yearly Current Assets VS Current LiabilitesBCSF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2

3. Growth

3.1 Past

The earnings per share for BCSF have decreased by -5.16% in the last year.
Measured over the past 5 years, BCSF shows a small growth in Earnings Per Share. The EPS has been growing by 5.38% on average per year.
The Revenue has decreased by -3.54% in the past year.
Measured over the past years, BCSF shows a quite strong growth in Revenue. The Revenue has been growing by 8.14% on average per year.
EPS 1Y (TTM)-5.16%
EPS 3Y15.4%
EPS 5Y5.38%
EPS Q2Q%-7.84%
Revenue 1Y (TTM)-3.54%
Revenue growth 3Y14.03%
Revenue growth 5Y8.14%
Sales Q2Q%-1.81%

3.2 Future

The Earnings Per Share is expected to decrease by -10.18% on average over the next years. This is quite bad
BCSF is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.03% yearly.
EPS Next Y-9.22%
EPS Next 2Y-10.72%
EPS Next 3Y-10.18%
EPS Next 5YN/A
Revenue Next Year-4.16%
Revenue Next 2Y-5.91%
Revenue Next 3Y-5.03%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BCSF Yearly Revenue VS EstimatesBCSF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
BCSF Yearly EPS VS EstimatesBCSF Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

5

4. Valuation

4.1 Price/Earnings Ratio

BCSF is valuated cheaply with a Price/Earnings ratio of 7.04.
Based on the Price/Earnings ratio, BCSF is valued cheaply inside the industry as 85.59% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of BCSF to the average of the S&P500 Index (27.77), we can say BCSF is valued rather cheaply.
BCSF is valuated reasonably with a Price/Forward Earnings ratio of 8.54.
Based on the Price/Forward Earnings ratio, BCSF is valued cheaply inside the industry as 80.93% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.23, BCSF is valued rather cheaply.
Industry RankSector Rank
PE 7.04
Fwd PE 8.54
BCSF Price Earnings VS Forward Price EarningsBCSF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BCSF Per share dataBCSF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A cheap valuation may be justified as BCSF's earnings are expected to decrease with -10.18% in the coming years.
PEG (NY)N/A
PEG (5Y)1.31
EPS Next 2Y-10.72%
EPS Next 3Y-10.18%

5

5. Dividend

5.1 Amount

BCSF has a Yearly Dividend Yield of 12.30%, which is a nice return.
Compared to an average industry Dividend Yield of 8.51, BCSF pays a bit more dividend than its industry peers.
BCSF's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 12.3%

5.2 History

The dividend of BCSF has a limited annual growth rate of 2.77%.
BCSF has been paying a dividend for over 5 years, so it has already some track record.
BCSF has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)2.77%
Div Incr Years3
Div Non Decr Years3
BCSF Yearly Dividends per shareBCSF Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

135.38% of the earnings are spent on dividend by BCSF. This is not a sustainable payout ratio.
BCSF's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP135.38%
EPS Next 2Y-10.72%
EPS Next 3Y-10.18%
BCSF Yearly Income VS Free CF VS DividendBCSF Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M
BCSF Dividend Payout.BCSF Dividend Payout, showing the Payout Ratio.BCSF Dividend Payout.PayoutRetained Earnings

BAIN CAPITAL SPECIALTY FINAN

NYSE:BCSF (10/21/2025, 8:04:00 PM)

After market: 14.68 +0.45 (+3.16%)

14.23

+0.22 (+1.57%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners33.3%
Inst Owner Change0.07%
Ins Owners0.63%
Ins Owner Change0%
Market Cap923.10M
Analysts77.78
Price Target16.49 (15.88%)
Short Float %0.52%
Short Ratio0.95
Dividend
Industry RankSector Rank
Dividend Yield 12.3%
Yearly Dividend1.77
Dividend Growth(5Y)2.77%
DP135.38%
Div Incr Years3
Div Non Decr Years3
Ex-Date12-16 2025-12-16 (0.03)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.14%
Min EPS beat(2)3.56%
Max EPS beat(2)4.72%
EPS beat(4)4
Avg EPS beat(4)4.81%
Min EPS beat(4)3.23%
Max EPS beat(4)7.71%
EPS beat(8)4
Avg EPS beat(8)1.22%
EPS beat(12)7
Avg EPS beat(12)7.05%
EPS beat(16)8
Avg EPS beat(16)5.98%
Revenue beat(2)1
Avg Revenue beat(2)-2.61%
Min Revenue beat(2)-7.71%
Max Revenue beat(2)2.49%
Revenue beat(4)2
Avg Revenue beat(4)-4.23%
Min Revenue beat(4)-12.42%
Max Revenue beat(4)2.49%
Revenue beat(8)4
Avg Revenue beat(8)-0.72%
Revenue beat(12)7
Avg Revenue beat(12)2.44%
Revenue beat(16)10
Avg Revenue beat(16)2.71%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.65%
EPS NY rev (1m)0%
EPS NY rev (3m)3.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.23%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.54%
Valuation
Industry RankSector Rank
PE 7.04
Fwd PE 8.54
P/S 3.25
P/FCF N/A
P/OCF N/A
P/B 0.81
P/tB 0.81
EV/EBITDA N/A
EPS(TTM)2.02
EY14.2%
EPS(NY)1.67
Fwd EY11.71%
FCF(TTM)-2.5
FCFYN/A
OCF(TTM)-2.5
OCFYN/A
SpS4.37
BVpS17.56
TBVpS17.56
PEG (NY)N/A
PEG (5Y)1.31
Profitability
Industry RankSector Rank
ROA 3.87%
ROE 9.44%
ROCE 4.94%
ROIC 3.9%
ROICexc 3.96%
ROICexgc 3.98%
OM 47.5%
PM (TTM) 37.89%
GM 51.17%
FCFM N/A
ROA(3y)4.53%
ROA(5y)3.71%
ROE(3y)10.26%
ROE(5y)8.49%
ROIC(3y)4.13%
ROIC(5y)3.56%
ROICexc(3y)4.22%
ROICexc(5y)3.66%
ROICexgc(3y)4.24%
ROICexgc(5y)3.67%
ROCE(3y)5.23%
ROCE(5y)4.51%
ROICexcg growth 3Y15.38%
ROICexcg growth 5Y11.17%
ROICexc growth 3Y15.28%
ROICexc growth 5Y11.09%
OM growth 3Y2.21%
OM growth 5Y2.08%
PM growth 3Y-12.39%
PM growth 5Y-3.82%
GM growth 3Y2.62%
GM growth 5Y2.37%
F-Score2
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.84
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.63
Quick Ratio 1.63
Altman-Z 0.6
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.16%
EPS 3Y15.4%
EPS 5Y5.38%
EPS Q2Q%-7.84%
EPS Next Y-9.22%
EPS Next 2Y-10.72%
EPS Next 3Y-10.18%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.54%
Revenue growth 3Y14.03%
Revenue growth 5Y8.14%
Sales Q2Q%-1.81%
Revenue Next Year-4.16%
Revenue Next 2Y-5.91%
Revenue Next 3Y-5.03%
Revenue Next 5YN/A
EBIT growth 1Y-4.73%
EBIT growth 3Y16.55%
EBIT growth 5Y10.39%
EBIT Next Year688.74%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-83.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-83.99%
OCF growth 3YN/A
OCF growth 5YN/A